Michael J. Banker
Pfizer (United States)(US)
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Drug Transport and Resistance Mechanisms, Computational Drug Discovery Methods, Liver Disease Diagnosis and Treatment, Glycosylation and Glycoproteins Research
Most-Cited Works
- → Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding(2003)299 cited
- → Discovery of Two Clinical Histamine H 3 Receptor Antagonists: trans - N -Ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidinylmethyl)phenyl]cyclobutanecarboxamide (PF-03654746) and trans -3-Fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]- N -(2-methylpropyl)cyclobutanecarboxamide (PF-03654764)(2011)107 cited
- → Plasma / Serum Protein Binding Determinations(2008)94 cited
- → Predicting safety toleration of pharmaceutical chemical leads: Cytotoxicity correlations to exploratory toxicity studies☆(2010)53 cited
- → Mechanistic insights on clearance and inhibition discordance between liver microsomes and hepatocytes when clearance in liver microsomes is higher than in hepatocytes(2020)37 cited
- → Problem Formulation and Option Assessment (PFOA) Linking Governance and Environmental Risk Assessment for Technologies: A Methodology for Problem Analysis of Nanotechnologies and Genetically Engineered Organisms(2009)26 cited
- → A high-efficiency vector for expression of foreign genes in myeloma cells(1988)18 cited
- → Enhanced Expression of an Immunoglobulin-Based Vector in Myeloma Cells Mediated by Coamplification with a Mutant Dihydrofolate Reductase Gene(1989)11 cited
- Sequence Specific RNA-Protein Interactions in Heterogenous Nuclear RNA of Adenovirus Infected HeLa Cells(1986)